Security key
59935V107
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)
CUSIP: 59935V107
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 21,048,124
- Total 13F value
- $135,124,913
- Share change
- +800,618
- SEC-reported price per share
- $6.42
- Number of holders
- 28
- Value change
- +$5,027,454
- Number of buys
- 15
- Number of sells
- 6
- Shares outstanding
- 124,817,707
Holder snapshot
6 facts
Security identity
1 fact
Report period
Q1 2022
Institutions
28
Top holders
10
MIST full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Milestone Pharmaceuticals Inc. SEC filings
Milestone Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59935V107
Recent filing periods:
Ownership snapshot
Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 3.5%
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 3.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
3.5%
ORBIMED ADVISORS LLC
2.1%
Novo Holdings A/S
2%
RA CAPITAL MANAGEMENT, L.P.
1.8%
Boxer Capital, LLC
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
Company
|
3.5%
|
$28,264,000
4,315,102 shares
|
— | 31 Dec 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.1%
|
$16,924,000
2,583,821 shares
|
— | 31 Dec 2021 |
| Novo Holdings A/S |
13F
Company
|
2%
|
$16,575,000
2,530,585 shares
|
— | 31 Dec 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
1.8%
|
$14,715,000
2,246,503 shares
|
— | 31 Dec 2021 |
| Boxer Capital, LLC |
13F
Company
|
1.8%
|
$14,665,000
2,238,861 shares
|
— | 31 Dec 2021 |
| Ikarian Capital, LLC |
13F
Company
|
1.4%
|
$11,464,000
1,750,043 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
28
Shares
21,048,124
Rows available
28
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
27
Q1 2022 holders
28
Holder diff
1
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend